1 Primitive defenses: cognitive aspects and therapeutic handling.

2 commentary: csf and plasma testosterone in attempted suicide

3 Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex.

4 Synthesis, pharmacological evaluation and QSAR study of 6- [3-(4-substituted phenylpiperazin-1-yl)propoxy]benzo[d][1,3] oxathiol-2-ones as potential antipsychotics

5 A Case of Complex Partial Seizures Presenting as Acute and Transient Psychotic Disorder

6 Is Antipsychotic Treatment Associated With Risk of Pneumonia in People With Serious Mental Illness?: The Roles of Severity of Psychiatric Symptoms and Global Functioning.

7 Effectiveness of a Community-Based Weight Management Program for Patients Taking Antidepressants and/or Antipsychotics.

8 Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study.

9 ISTDP and Its Contribution to the Understanding and Treatment of Psychotic Disorders.

10 Determination of antipsychotic drugs in oral fluid using dried saliva spots by gas chromatography-tandem mass spectrometry.

11 Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic Disorders.

12 Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.

13 Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders Among Adolescents: A 3-Year Cohort Study.

14 Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics-HDC/DFMC Bridge Project, Phase 1: Group Concept Mapping.

15 UFC as a predictor of response in major depression with psychotic features

16 Analyzing Nanotheraputics Based Approaches For The Management Of Psychotic Disorders.

17 Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.

18 Preventing Suicide among Psychiatric Inpatients with Psychotic Depression.

19 A case of madness resulting in a fortunate outcome; case report of a psychotic break as a result of cortisol secreting thymic neuroendocrine thymic tumor.

20 Age at Migration and the Risk of Psychotic Disorders: A Systematic Review and Meta-Analysis.

21 The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness.

22 Focused Ethnographic Examination of Barriers to Use of Long-Acting Injectable Antipsychotics.

23 Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study.

24 Costs versus benefits and impact on life goals should be part of communication around anti-psychotic treatment duration in schizophrenia

25 Feasibility and Efficacy of Prolonged Exposure for PTSD among Individuals with a Psychotic Spectrum Disorder

26 Aggressive Behavior, Hostility, and Associated Care Needs in Patients With Psychotic Disorders: A 6-Year Follow-Up Study.

27 Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study.

28 Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring

29 [What support of young presenting a first psychotic episode, when schooling is being challenged?]

30 Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.

31 Loneliness and psychotic experiences in a general population sample.

32 [Sponsorship by a peer and recovery for persons suffering of a severe psychotic condition].

33 Improved Prescriber Adherence to Guidelines on Antipsychotic Medication Management Through Increased Access to Metabolic Monitoring Forms.

34 Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.

35 Antipsychotic Drug Treatment in First-Episode Mania: A 6-Month Longitudinal Study

36 Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

37 Sleep Apnea Associated With Antipsychotic-Induced Obesity

38 Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review

39 atypical case of wilson's disease with psychotic onset, low 24 hour urine copper and the absence of kayser-fleischer rings

40 a double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania

41 weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies

42 use of antipsychotics and tardive dyskinesia

43 post traumatic stress disorders (ptsd) with severe depression symptoms with acute psychotic in patient with history as a pedophile victims and domestic violence in 22 years old man : a case report

44 decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

45 commentary: eysenck personality questionnaire revised psychoticism predictsmotivational-somatic symptoms of depression in breast cancer survivors.

46 blonanserin extensively occupies rat dopamine d3 receptors at antipsychotic dose range

47 a comparison of complex sleep behaviors with two short-acting z-hypnosedative drugs in nonpsychotic patients

48 pattern of antipsychotic use and its determinants in razi psychiatric hospital

49 systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia

50 long-acting injectable antipsychotics in first-episode schizophrenia

51 effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal 1h-mrs studies

52 psychiatric manifestations of sporadic creutzfeldt-jakob disease simulate depressive disorder with psychotic symptoms

53 antipsychotic treatments; focus on lurasidone

54 impulsivity and novel object recognition test of rat model for vascular cognitive impairment after antipsychotics treatment

55 atypical antipsychotic-induced parkinsonism: a patient case with cyp enzyme implications

56 the efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with parkinson’s disease

57 trajectories of early childhood developmental skills and early adolescent psychotic experiences: findings from the alspac uk birth cohort

58 geographic distribution of antipsychotic use in medicare part d patients

59 ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation

60 the acceptability, usability and short-term outcomes of get real: a web-based program for psychotic-like experiences (ples)

61 association between anti-toxoplasma gondii antibodies and schizophrenia and psychotic bipolar in patients hospitalized in the psychiatric ward

62 lipid profile in antipsychotic drug users: a comparative study

63 direct and indirect drug design approaches for the development of novel tricyclic antipsychotics: potential 5-ht2a antagonist

64 effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update

65 recovery of behavioral changes and compromised white matter in c57bl/6 mice exposed to cuprizone: effects of antipsychotic drugs

66 symptom profile and severity in a sample of nigerians with psychotic versus nonpsychotic major depression

67 serum substance p levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics

68 possible association between haplotypes of the fkbp5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder

69 deletion involving the 7q31-32 band at the cadps2 gene locus in a patient with autism spectrum disorder and recurrent psychotic syndrome triggered by stress

70 glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

71 temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper

72 mitragyna speciosa leaf extract exhibits antipsychotic-like effect with the potential to alleviate positive and negative symptoms of psychosis in mice

73 self-reported visual perceptual abnormalities are strongly associated with core clinical features in psychotic disorders

74 managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach

75 psychotic-like experiences and their cognitive appraisal under short-term sensory deprivation

76 psychosomatic or somatopsychotic? a critical analysis of psychosomatic medicine

77 risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study

78 Introduction: Cardiovascular and Metabolic Risks Associated With Schizophrenia and Antipsychotic Drug Treatment

79 Mechanisms and Risks of Electrocardiographic QT Interval Prolongation When Using Antipsychotic Drugs

80 Assessing Cardiovascular Risks Versus Clinical Benefits of Atypical Antipsychotic Drug Treatment

81 A Case of Atypical Antipsychotic-Induced Somnambulism: A Class Effect

82 Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics

83 Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

84 Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management

85 A Review of Sensitivity and Tolerability of Antipsychotics in Patients With Bipolar Disorder or Schizophrenia: Focus on Somnolence

86 Sexual Dysfunction in Patients Treated With Atypical Antipsychotics

87 The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review

88 Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

89 Comparing the Use and Discontinuation of Antipsychotics in Clinical Practice: An Observational Study

90 Psychotic-like experiences among 9,564 Kenyan adolescents and young adults

91 Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia.

92 Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis.

93 [Profile of population targeted by violent behavior of psychotic patients].

94 From crisis to control: The role of long-acting injectable antipsychotics in reducing psychiatric service use in bipolar disorder

Keyword Connections

Journals

Research Groups

Bibliographies